Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 6/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.39 |
| ▸ | MAPK14 | Q16539 | 5/20 | 0.36 |
| ▸ | KIT | P10721 | 1/20 | 0.36 |
| ▸ | SLC34A1 | Q06495 | 2/20 | 0.35 |
| ▸ | GRM5 | P41594 | 1/20 | 0.35 |
| ▸ | BRD4 | O60885 | 1/20 | 0.34 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.34 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.34 |
| ▸ | RORC | P51449 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7513789 | 0.87 | PTGS2 (0.36) | PTGS2PTGS1KITRORC | |
| SCHEMBL8604204 | 0.77 | EGLN2 (0.33) | PDE4BPDE4D | |
| SCHEMBL7506362 | 0.77 | PTGS2 (0.30) | PTGS2 | |
| SCHEMBL7741912 | 0.76 | VCAM1 (0.34) | PTGS2GAA | |
| SCHEMBL7747366 | 0.75 | SLC34A1 (0.36) | MAPK14SLC34A1GRM5 | |
| SCHEMBL15332993 | 0.74 | MAPK14 (0.38) | MAPK14SLC34A1GRM5BRD4GAA | |
| SCHEMBL7509183 | 0.73 | VCAM1 (0.33) | PTGS2 | |
| SCHEMBL9531790 | 0.73 | PTGS2 (0.37) | PTGS2PTGS1KITSLC34A1 | |
| SCHEMBL9531665 | 0.73 | KIF11 (0.39) | PTGS2PTGS1KITSLC34A1 | |
| SCHEMBL9696394 | 0.72 | RORC (0.31) | RORCGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2001019820-A1 | SUBSTITUTED PYRAZOL-3-YLBENZOXAZINONES | BASF AKTIENGESELLSCHAFT (DE) | 2001-03-22 | — | — | WO | disclosed |